PATRICK GREGORY S (VP, Chief Financial Officer) sold 24.6% of their position (15K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $347.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/11/2020ACC: 0001104659-20-059729
Officer· VP, Chief Financial Officer
Since Jul 2018
-15K
Net shares
Net seller
$347.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$9.13
Trade value
$136.95K
% of position
32.6%
5/8/2020
46.06K→61.06K
Common Stock
Direct
Shares
−15K
Price / share
$23.14
Trade value
$347.03K
% of position
24.6%
5/8/2020
61.06K→46.06K
Total
Net shares
+0.00
Net value
-$210.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/8/2020 | M · Option Exercise | +15K | $9.13 | $136.95K | 32.6% | 46.06K | 61.06K |
| Common Stock Direct | 5/8/2020 | S · Sale | −15K | $23.14 | $347.03K | 24.6% | 61.06K | 46.06K |
| Total | +0.00 | -$210.08K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
9.13
Held after
0.00
Exercisable
—
5/8/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock15K shares | 5/8/2020 | M · Option Exercise | −15K | 9.13 | — | 0.00 |